Estonia’s Rise as Europe’s Fintech Powerhouse
12/12/2024
Estonia, a small Baltic country with a population of 1.4 million, is in the news for all the right reasons:...
read more
Japan’s EV Hesitation: The High Cost of Delay to Its Automotive Sector
05/12/2024
Japan is the world’s fourth largest automotive manufacturer, behind China, the USA, and India. The country has been long known...
read more
Open Banking Sparking a Wave of Innovation in Financial Services
21/11/2024
The adoption of open banking is leading to innovation across financial solutions such as account-to-account payments (A2A), personal finance management...
read more
Continuous Glucose Monitoring Devices: Overcoming Barriers in LMICs
12/11/2024
The rising prevalence of diabetes in low- and middle-income countries (LMICs) underscores the need for advanced diabetes management solutions. Continuous...
read more
The Future of Diabetes Care: Key Innovations in the Continuous Glucose Monitoring
21/10/2024
Continuous glucose monitors (CGM) represent a disruptive innovation that has transformed the diabetes management landscape. In recent years, the CGM...
read more
NVIDIA’s Meteoric Rise: Can the AI Chip Giant Sustain Its Dominance?
17/10/2024
NVIDIA has grown exponentially in recent years. The company made significant strides as an early entrant into the AI chip...
read more
Mind over Matter: How Non-invasive Neuromodulation Is Becoming the Future of Pain Management and Beyond
08/10/2024
Scientists have been researching the possibility of using electrical impulses to treat many health conditions. The starting point was the...
read more
New Directions in Alzheimer’s Diagnostics: Will Blood Tests Replace CSF and PET?
30/09/2024
Around three-fourths of dementia cases continue to remain undiagnosed even though the incidence of Alzheimer’s disease (AD) is rapidly growing...
read more
Phase 3 Drug Candidates – A Ray of Hope in Alzheimer’s Disease Bleak Treatment Landscape?
26/09/2024
Many biopharmaceutical companies, such as AriBio, Annovis Bio, Athira Pharma, Cassava Sciences, and Alzheon, specializing in treating neurodegenerative diseases, are...
read more
Pharma Companies Navigate Their Way through Ac-225 amidst Supply Constraints
19/09/2024
Pharma companies have been increasingly investing in developing targeted alpha therapies for cancer treatment, using alpha-emitting isotopes such as Ac-225....
read more